David M. Rubenstein - Aug 5, 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Director
Signature
/s/ James Dillon, As Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Aug 5, 2025
Transactions value $
$0
Form type
4
Date filed
8/6/2025, 04:06 PM
Previous filing
May 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rubenstein David M. Director C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE /s/ James Dillon, As Attorney-in-Fact 2025-08-06 0001543895

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +850 +125.55% 1.53K Aug 5, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -850 -100% $0.00 0 Aug 5, 2025 Common Stock 850 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 The shares subject to this restricted stock unit award vested in full on August 5, 2025.